Tevethia S S, Tevethia M J, Lewis A J, Reddy V B, Weissman S M
Virology. 1983 Jul 30;128(2):319-30. doi: 10.1016/0042-6822(83)90259-3.
Mouse LTK- cells (H-2k) were transfected with a series of recombinant plasmids consisting of the herpes simplex virus type 1 thymidine kinase (TK) gene linked to fragments of SV40 DNA coding for portions of SV40 T antigen in pBR322, and TK+ transformants (LTK+) were selected in HAT medium. The TK+ transformants were analyzed for SV40 transplantation rejection antigen (TrAg) at the cell surface by reacting them with cytotoxic lymphocytes (CTL) generated to SV40 TrAg in C3H/HeJ (H-2k) mice. The results indicated that the cells transformed by pVBETK-1 and synthesizing full size SV40 large T antigen were efficiently lysed by SV40 CTL. In addition, cells transformed by the plasmid pVBt1TK-1 and synthesizing a truncated 33 K T antigen were also found to be susceptible to lysis by the CTL. However, LTK+ cells that were transformed with the plasmid pVBt2TK-1 and which synthesized a truncated T antigen of 12.3 K did not provide a target for SV40 CTL nor did pVBETK-1-transformed cells that did not express any of the SV40 tumor antigens. Only the pVBETK-1-transformed cells that express 94 K T antigen were able to immunize mice against a challenge of syngeneic SV40-transformed cells. These results suggest that the TrAg expression at the cell membranes of transformed cells may be associated with the proximal half of SV40 T antigen.
将一系列重组质粒转染小鼠LTK-细胞(H-2k),这些重组质粒由与编码SV40 T抗原部分片段的SV40 DNA片段相连的单纯疱疹病毒1型胸苷激酶(TK)基因组成,位于pBR322载体中,然后在HAT培养基中筛选TK+转化体(LTK+)。通过将TK+转化体与在C3H/HeJ(H-2k)小鼠中针对SV40移植排斥抗原(TrAg)产生的细胞毒性淋巴细胞(CTL)反应,分析其细胞表面的SV40移植排斥抗原(TrAg)。结果表明,被pVBETK-1转化并合成全长SV40大T抗原的细胞被SV40 CTL有效裂解。此外,发现被质粒pVBt1TK-1转化并合成截短的33K T抗原的细胞也易被CTL裂解。然而,被质粒pVBt2TK-1转化并合成12.3K截短T抗原的LTK+细胞以及不表达任何SV40肿瘤抗原的pVBETK-1转化细胞,都不能成为SV40 CTL的靶细胞。只有表达94K T抗原的pVBETK-1转化细胞能够使小鼠对同基因SV40转化细胞的攻击产生免疫。这些结果表明,转化细胞膜上的TrAg表达可能与SV40 T抗原的近端一半相关。